X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 16c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.16). Revenue for the quarter came in at $2.71 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.16). Revenue for the quarter came in at $2.71 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.